跳至主要内容
临床试验/NCT07034339
NCT07034339招募中不适用

Construction and Clinical Application of the Immune Map of Pancreatic Cancer Evolution

First Affiliated Hospital of Zhejiang University1 个研究点 分布在 1 个国家目标入组 1,500 人开始时间: 2025年5月21日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
1,500
试验地点
1
主要终点
Pancreatic tumor resection

研究概览

简要总结

The intricate interplay between systemic immunity and tumors profoundly influences not only the onset and progression of tumors but also serves as a crucial window into understanding tumor evolution and treatment status. This project aims to establish a large, multi-center pancreatic cancer cohort and a standardized clinical sample repository, capturing multimodal immunity big data on pancreatic cancer occurrence, progression, and treatment response across the spatial dimension of "peripheral versus local" and the temporal dimension of "tumor evolution/pre- and post-treatment." By integrating patient imaging and clinical information, the investigators will develop a technical platform for intelligent extraction and fusion analysis of cross-scale, multimodal data, thereby mapping the immunity landscape of pancreatic cancer evolution, identifying characteristic changes in immunity parameters, and devising an AI model for early pancreatic cancer diagnosis with high accuracy and robust generalization capabilities, while also exploring the model's interpretability. Additionally, the investigators will focus on specific immune cell subsets associated with pancreatic cancer evolution and treatment response, elucidating their roles and mechanisms in the occurrence, development, and drug resistance of pancreatic cancer. This project will establish a high-quality, standardized, and shareable pancreatic cancer immunity sample and data repository, refine the framework for multi-dimensional immunity data fusion and analysis, and create a time-space atlas of local and systemic immunity in pancreatic cancer. This will facilitate a deeper understanding of the dynamics of systemic and local immunity in early-stage pancreatic cancer and at various stages of its evolution, offering novel insights and approaches for the diagnosis and treatment of pancreatic cancer.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Healthy individuals without benign or malignant liver, gallbladder, and pancreas diseases
  • •Primary PDAC
  • •Patients with benign pancreatic tumors
  • •IPMN patients diagnosed by pathology/imaging

排除标准

  • •Having autoimmune diseases
  • •Accompanied by other malignant tumors
  • •History of tumor treatment (except thyroid cancer and breast cancer, cured for more than 5 years)
  • •Acute infection
  • •History of blood transfusion within the past 6 months, or use of drugs that affect peripheral blood components such as recombinant human erythropoietin and interleukin within 2 weeks
  • •Organ decompensation dysfunction
  • •Immunodeficiency syndrome
  • •Hematological precancerous lesions
  • •Accept immunosuppressive therapy
  • •Diagnosed coagulation disease

结局指标

主要结局

Pancreatic tumor resection

时间窗: 3 years

Number of participants with pancreatic cancer

次要结局

未报告次要终点

研究者

发起方
First Affiliated Hospital of Zhejiang University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Qi Zhang

Professor

First Affiliated Hospital of Zhejiang University

研究点 (1)

Loading locations...

相似试验

Construction and Clinical Application of the Immune... | 临床试验